Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study
Clinical trial NCT00474591 · UNKNOWN
Trial details
- NCT number
- NCT00474591
- Sponsor
- Hamilton Health Sciences Corporation
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.